• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Yellow fever vaccination in Malaya by subcutaneous injection and multiple puncture. Neutralizing antibody responses in persons with and without pre-existing antibody to related viruses.马来亚通过皮下注射和多点针刺进行黄热病疫苗接种。有和没有针对相关病毒的预先存在抗体的人群中的中和抗体反应。
Bull World Health Organ. 1962;27(6):717-27.
2
YELLOW FEVER VACCINATION IN MALAYA BY SUBCUTANEOUS INJECTION AND MULTIPLE PUNCTURE. HAEMAGGLUTININ-INHIBITING ANTIBODY RESPONSES IN PERSONS WITH AND WITHOUT PRE-EXISTING ANTIBODY.马来亚通过皮下注射和多点针刺进行黄热病疫苗接种。有和无预先存在抗体的人群中的血凝抑制抗体反应。
Bull World Health Organ. 1963;29(1):75-80.
3
Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine.接种17D疫苗17年后针对黄热病的中和抗体及血凝抑制抗体
Bull World Health Organ. 1962;27(6):699-707.
4
Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine.B组虫媒病毒的免疫学研究。IV. 接种17D株黄热病疫苗后黄热病抗体的持久性。
Am J Trop Med Hyg. 1963 Mar;12:230-5.
5
Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.小鼠中的致死性17D型黄热脑炎。I. 针对17D型黄热病毒和登革2型病毒包膜蛋白的单克隆抗体的被动保护作用
J Gen Virol. 1986 Feb;67 ( Pt 2):229-34. doi: 10.1099/0022-1317-67-2-229.
6
Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.接种黄热病病毒17D株的恒河猴的血清学反应。
Bull World Health Organ. 1962;27(6):709-15.
7
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures.一种在Vero细胞培养物中培养的灭活黄热病17DD疫苗。
Vaccine. 2015 Aug 20;33(35):4261-8. doi: 10.1016/j.vaccine.2015.03.077. Epub 2015 Apr 7.
8
The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay.氯喹预防对黄热病疫苗抗体反应的影响:蚀斑减少中和试验与酶联免疫吸附测定的比较
Am J Trop Med Hyg. 1991 Jan;44(1):79-82. doi: 10.4269/ajtmh.1991.44.79.
9
Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.黄热病疫苗。五、用不同剂量17D疫苗接种的猴子的抗体反应。
Appl Microbiol. 1972 May;23(5):908-13. doi: 10.1128/am.23.5.908-913.1972.
10
Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.17D 黄热病疫苗免疫后 30 - 35 年中和抗体的持续性。
Bull World Health Organ. 1981;59(6):895-900.

引用本文的文献

1
The Absence of Yellow Fever in Asia: History, Hypotheses, Vector Dispersal, Possibility of YF in Asia, and Other Enigmas.亚洲无黄热病:历史、假说、媒介传播、亚洲出现黄热病的可能性及其他未解之谜。
Viruses. 2020 Nov 25;12(12):1349. doi: 10.3390/v12121349.
2
Is there a risk of yellow fever virus transmission in South Asian countries with hyperendemic dengue?在登革热高度流行的南亚国家,是否存在黄热病病毒传播的风险?
Biomed Res Int. 2013;2013:905043. doi: 10.1155/2013/905043. Epub 2013 Dec 3.
3
17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study.17DD 黄热病疫苗:免疫原性和安全性的双盲、随机临床试验,剂量反应研究。
Hum Vaccin Immunother. 2013 Apr;9(4):879-88. doi: 10.4161/hv.22982. Epub 2013 Jan 30.
4
The global distribution of yellow fever and dengue.黄热病和登革热的全球分布情况。
Adv Parasitol. 2006;62:181-220. doi: 10.1016/S0065-308X(05)62006-4.
5
YELLOW FEVER VACCINATION IN MALAYA BY SUBCUTANEOUS INJECTION AND MULTIPLE PUNCTURE. HAEMAGGLUTININ-INHIBITING ANTIBODY RESPONSES IN PERSONS WITH AND WITHOUT PRE-EXISTING ANTIBODY.马来亚通过皮下注射和多点针刺进行黄热病疫苗接种。有和无预先存在抗体的人群中的血凝抑制抗体反应。
Bull World Health Organ. 1963;29(1):75-80.
6
Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.17D 黄热病疫苗免疫后 30 - 35 年中和抗体的持续性。
Bull World Health Organ. 1981;59(6):895-900.
7
A yellow fever vaccine free from avian leucosis viruses.一种不含禽白血病病毒的黄热病疫苗。
J Hyg (Lond). 1967 Dec;65(4):505-13. doi: 10.1017/s0022172400046040.
8
Leukaemia and neoplastic processes treated with Langat and Kyasanur Forest disease viruses: a clinical and laboratory study of 28 patients.用兰加特病毒和基孔肯雅森林病病毒治疗白血病和肿瘤性疾病:28例患者的临床和实验室研究
Br Med J. 1966 Jan 29;1(5482):258-66. doi: 10.1136/bmj.1.5482.258.
9
Evaluation of survival in challenge experiments.挑战实验中的生存评估。
Microbiol Rev. 1978 Mar;42(1):237-49. doi: 10.1128/mr.42.1.237-249.1978.

本文引用的文献

1
A preliminary evaluation of the immunizing power of chick-embryo 17 D yellow fever vaccine inoculated by scarification.划痕接种鸡胚17D黄热病疫苗免疫效力的初步评估。
Am J Hyg. 1952 Jan;55(1):140-53. doi: 10.1093/oxfordjournals.aje.a119502.
2
A combined yellow fever-smallpox vaccine for cutaneous application.一种用于皮肤接种的黄热病-天花联合疫苗。
Am J Hyg. 1951 Jul;54(1):50-70. doi: 10.1093/oxfordjournals.aje.a119470.
3
Yellow fever vaccination by scarification with 17D vaccine.采用17D疫苗划痕法进行黄热病疫苗接种。
Trop Geogr Med. 1958 Sep;10(3):289-91.
4
The distribution of antibodies to Japanese Encephalitis, dengue, and yellow fever viruses in five rural communities in Malaya.马来西亚五个农村社区中针对日本脑炎、登革热和黄热病病毒的抗体分布情况。
Trans R Soc Trop Med Hyg. 1958 May;52(3):237-52. doi: 10.1016/0035-9203(58)90083-x.
5
The use of survival time in the analysis of neutralization tests for serum antibody surveys.在血清抗体调查的中和试验分析中生存时间的应用。
J Hyg (Lond). 1957 Jun;55(2):224-38. doi: 10.1017/s0022172400037128.
6
Isolation of three strains of type 1 dengue virus from a local outbreak of the disease in Malaya.从马来西亚当地登革热疫情中分离出三株1型登革热病毒。
J Hyg (Lond). 1956 Dec;54(4):569-80. doi: 10.1017/s0022172400044843.
7
A virus resembling Russian spring-summer encephalitis virus from an ixodid tick in Malaya.从马来西亚一只硬蜱中分离出的一种类似俄罗斯春夏脑炎病毒的病毒。
Nature. 1956 Sep 15;178(4533):581-2. doi: 10.1038/178581a0.
8
Vaccination by scarification with 17D yellow fever vaccine prepared at Yaba, Lagos, Nigeria.使用在尼日利亚拉各斯雅巴制备的17D黄热病疫苗通过划痕法进行接种。
Ann Trop Med Parasitol. 1953 Dec;47(4):381-93. doi: 10.1080/00034983.1953.11685585.
9
Japanese type B encephalitis in Malaya.马来亚的日本乙型脑炎
Ann Trop Med Parasitol. 1952 Nov;46(3):220-6. doi: 10.1080/00034983.1952.11685526.
10
Japanese encephalitis in Malaya. I. Isolation of virus and serologic evidence of human and equine infections.马来亚的日本脑炎。一、病毒分离及人类和马感染的血清学证据。
Am J Hyg. 1952 Nov;56(3):320-33.

马来亚通过皮下注射和多点针刺进行黄热病疫苗接种。有和没有针对相关病毒的预先存在抗体的人群中的中和抗体反应。

Yellow fever vaccination in Malaya by subcutaneous injection and multiple puncture. Neutralizing antibody responses in persons with and without pre-existing antibody to related viruses.

作者信息

SMITH C E, TURNER L H, ARMITAGE P

出版信息

Bull World Health Organ. 1962;27(6):717-27.

PMID:13993152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2555834/
Abstract

Because of the risk of introduction of yellow fever to South-East Asia, comparative studies were made of yellow fever vaccination in Malayans who had a high prevalence of antibody to related viruses and in volunteers without related antibody. The proportions of positive neutralizing antibody responses to subcutaneous vaccination with 17D vaccine were not significantly different between volunteers with and without heterologous antibody but the degree of antibody response was greater in those without. The ID(50) of 17D in both groups was about 5 mouse intracerebral LD(50). Multiple puncture vaccination with 17D gave a much lower response rate than subcutaneous vaccination in volunteers with heterologous antibody. In both groups subcutaneous doses of about 50 mouse intracerebral LD(50) gave larger antibody responses than higher doses. The neutralizing indices and analysis of results were calculated by a method based on the survival time of the mice. This method, which has advantages over that of Reed & Muench, is fully described in an annex to this paper.

摘要

由于存在将黄热病引入东南亚的风险,因此对马来人中黄热病疫苗接种情况进行了比较研究,这些马来人对相关病毒抗体的患病率较高,同时也对无相关抗体的志愿者进行了研究。接种17D疫苗后,有和没有异源抗体的志愿者中,产生阳性中和抗体反应的比例没有显著差异,但没有异源抗体的志愿者抗体反应程度更大。两组中17D的半数感染剂量(ID50)约为5个小鼠脑内半数致死剂量(LD50)。在有异源抗体的志愿者中,17D多点穿刺接种产生的反应率远低于皮下接种。在两组中,约5个小鼠脑内LD50的皮下剂量比更高剂量产生的抗体反应更大。中和指数及结果分析采用基于小鼠存活时间的方法计算。该方法比里德和门什的方法更具优势,本文附录中有详细描述。